Ultragenyx Pharmaceutical Inc.
2019 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 7,605 | 0.0% | 331,169 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 14,195 | 0.0% | 390,389 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 10,623 | 0.0% | 293,374 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 9,112 | 0.0% | 216,587 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 13,224 | 0.0% | 238,055 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 10,157 | 0.0% | 247,138 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 13,424 | 0.0% | 287,504 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 13,023 | 0.0% | 272,339 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 8,587 | 0.0% | 240,857 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 11,206 | 0.0% | 242,928 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 3,009 | 0.0% | 75,032 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 3,807 | 0.0% | 84,220 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 3,053 | 0.0% | 75,235 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 5,191 | 0.0% | 86,190 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 5,982 | 0.0% | 83,794 | 3/31/2022 |
| 2021 Q1 | 5/3/2021 | 4,050 | 0.0% | 35,571 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 5,150 | 0.0% | 37,202 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 2,723 | 0.0% | 33,131 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 2,484 | 0.0% | 33,725 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 1,541 | 0.0% | 34,687 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,405 | 0.0% | 32,889 | 12/31/2019 |